drug

M6223

1 story · latest Sep 1, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Merck KGaA

Timeline

JAVELIN Bladder Medley posts results; avelumab combos tested as maintenance therapy

Sep 1Trial updateavelumab M6223

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.